
BELITE BIO, INC
BELITE BIO, INC (BLTE)
WebsitePrice
Market cap
Next catalystFeb 12, 2027Tinlarebant — STGD1 regulatory review and clinical development · Regulatory decisionSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
PreINDP1P2P3FilingApproved
Financial position
Company funding outlook
Upcoming milestones
Financial history
Annual trends
| Reported item | |||||
|---|---|---|---|---|---|
Reported shares and borrowings
Ownership and institutions
| Status | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|